Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 3
1957 1
1958 3
1959 2
1961 7
1962 11
1963 5
1964 8
1965 14
1966 8
1967 34
1968 29
1969 38
1970 24
1971 20
1972 22
1973 24
1974 25
1975 28
1976 26
1977 32
1978 37
1979 44
1980 46
1981 47
1982 61
1983 54
1984 63
1985 77
1986 80
1987 78
1988 92
1989 100
1990 107
1991 108
1992 132
1993 162
1994 126
1995 122
1996 138
1997 153
1998 176
1999 184
2000 191
2001 206
2002 243
2003 228
2004 271
2005 269
2006 284
2007 277
2008 309
2009 289
2010 302
2011 395
2012 386
2013 402
2014 370
2015 383
2016 432
2017 401
2018 389
2019 404
2020 467
2021 487
2022 189
Text availability
Article attribute
Article type
Publication date

Search Results

9,191 results
Results by year
Filters applied: . Clear all
Page 1
Evidence-based clinical practice guidelines for management of colorectal polyps.
Tanaka S, Saitoh Y, Matsuda T, Igarashi M, Matsumoto T, Iwao Y, Suzuki Y, Nozaki R, Sugai T, Oka S, Itabashi M, Sugihara KI, Tsuruta O, Hirata I, Nishida H, Miwa H, Enomoto N, Shimosegawa T, Koike K. Tanaka S, et al. Among authors: matsumoto t. J Gastroenterol. 2021 Apr;56(4):323-335. doi: 10.1007/s00535-021-01776-1. Epub 2021 Mar 12. J Gastroenterol. 2021. PMID: 33710392 Free PMC article. Review.
Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion.
Okumura S, Konishi Y, Narukawa M, Sugiura Y, Yoshimoto S, Arai Y, Sato S, Yoshida Y, Tsuji S, Uemura K, Wakita M, Matsudaira T, Matsumoto T, Kawamoto S, Takahashi A, Itatani Y, Miki H, Takamatsu M, Obama K, Takeuchi K, Suematsu M, Ohtani N, Fukunaga Y, Ueno M, Sakai Y, Nagayama S, Hara E. Okumura S, et al. Among authors: matsumoto t. Nat Commun. 2021 Sep 28;12(1):5674. doi: 10.1038/s41467-021-25965-x. Nat Commun. 2021. PMID: 34584098 Free PMC article.
Corrigenda.
Matsumoto T, Takayama K, Ishida K, Hayashi S, Hashimoto S, Kuroda R. Matsumoto T, et al. Bone Joint J. 2021 Oct;103-B(10):1641. doi: 10.1302/0301-620X.103B10.BJJ-2021-00021. Bone Joint J. 2021. PMID: 34587812 No abstract available.
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial.
Kobayashi T, Motoya S, Nakamura S, Yamamoto T, Nagahori M, Tanaka S, Hisamatsu T, Hirai F, Nakase H, Watanabe K, Matsumoto T, Tanaka M, Abe T, Suzuki Y, Watanabe M, Hibi T; HAYABUSA Study Group. Kobayashi T, et al. Among authors: matsumoto t. Lancet Gastroenterol Hepatol. 2021 Jun;6(6):429-437. doi: 10.1016/S2468-1253(21)00062-5. Epub 2021 Apr 20. Lancet Gastroenterol Hepatol. 2021. PMID: 33887262 Clinical Trial.
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).
Hamanishi J, Takeshima N, Katsumata N, Ushijima K, Kimura T, Takeuchi S, Matsumoto K, Ito K, Mandai M, Nakai H, Sakuragi N, Watari H, Takahashi N, Kato H, Hasegawa K, Yonemori K, Mizuno M, Takehara K, Niikura H, Sawasaki T, Nakao S, Saito T, Enomoto T, Nagase S, Suzuki N, Matsumoto T, Kondo E, Sonoda K, Aihara S, Aoki Y, Okamoto A, Takano H, Kobayashi H, Kato H, Terai Y, Takazawa A, Takahashi Y, Namba Y, Aoki D, Fujiwara K, Sugiyama T, Konishi I. Hamanishi J, et al. Among authors: matsumoto t. J Clin Oncol. 2021 Nov 20;39(33):3671-3681. doi: 10.1200/JCO.21.00334. Epub 2021 Sep 2. J Clin Oncol. 2021. PMID: 34473544 Clinical Trial.
Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.
Shinzaki S, Matsuoka K, Tanaka H, Takeshima F, Kato S, Torisu T, Ohta Y, Watanabe K, Nakamura S, Yoshimura N, Kobayashi T, Shiotani A, Hirai F, Hiraoka S, Watanabe M, Matsuura M, Nishimoto S, Mizuno S, Iijima H, Takehara T, Naka T, Kanai T, Matsumoto T. Shinzaki S, et al. Among authors: matsumoto t. J Gastroenterol. 2021 Jun;56(6):560-569. doi: 10.1007/s00535-021-01793-0. Epub 2021 May 3. J Gastroenterol. 2021. PMID: 33942166 Free PMC article.
Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial.
Fujiwara K, Fujiwara H, Yoshida H, Satoh T, Yonemori K, Nagao S, Matsumoto T, Kobayashi H, Bourgeois H, Harter P, Mosconi AM, Vazquez IP, Reinthaller A, Fujita T, Rowe P, Pujade-Lauraine E, Ray-Coquard I. Fujiwara K, et al. Among authors: matsumoto t. J Gynecol Oncol. 2021 Sep;32(5):e82. doi: 10.3802/jgo.2021.32.e82. J Gynecol Oncol. 2021. PMID: 34378365 Free PMC article. Clinical Trial.
Tribute to Our Reviewers.
Matsumoto T. Matsumoto T. Dig Endosc. 2021 Nov;33(7):1199-1201. doi: 10.1111/den.14126. Dig Endosc. 2021. PMID: 34735744 No abstract available.
Subcutaneous giant trichoblastoma in the abdomen.
Goto K, Kono M, Urata T, Hasegawa-Murakami Y, Matsumoto T, Yamashita Y, Yokota K, Akiyama M. Goto K, et al. Among authors: matsumoto t. J Dermatol. 2021 Aug;48(8):e393-e394. doi: 10.1111/1346-8138.15961. Epub 2021 May 8. J Dermatol. 2021. PMID: 33963593 No abstract available.
Altered chemosensitivity to CO2 during exercise.
Yamashiro SM, Kato T, Matsumoto T. Yamashiro SM, et al. Among authors: matsumoto t. Physiol Rep. 2021 Jun;9(11):e14882. doi: 10.14814/phy2.14882. Physiol Rep. 2021. PMID: 34110716 Free PMC article.
9,191 results